Global Image Guided Radiotherapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Image Guided Radiotherapy Market is presumed to reach the market size of nearly USD 4.62 Billion by 2032 from USD 2.35 Billion in 2023 with a CAGR of 7.78% under the study period 2024-2032.

Image guided radiotherapy (IGRT) is a technique that utilizes imaging technologies to enhance the precision and effectiveness of radiation therapy for cancer treatment. By incorporating real-time imaging modalities such as CT, MRI, or X-ray into the radiotherapy process, IGRT allows clinicians to accurately target tumors while minimizing exposure to surrounding healthy tissues. This technique improves the accuracy of radiation delivery, adjusts for patient movement, and ensures optimal treatment outcomes. IGRT is crucial in modern cancer care, providing higher doses of radiation to cancerous tissues with greater precision, thereby improving tumor control and reducing side effects.

MARKET DYNAMICS

The image guided radiotherapy market is fuelled by the spurring incidence of cancer and the rising demand for precise and effective treatment options. Integrating advanced imaging technologies with radiotherapy systems enhances treatment accuracy and patient outcomes, supporting market growth. Technological advancements, such as the development of high-definition imaging and motion management systems, offer opportunities for improved precision and personalized treatment. The rising focus on reducing radiation exposure to healthy tissues and expanding cancer treatment centers globally contribute to image guided radiotherapy market expansion. Additionally, the growing emphasis on multidisciplinary cancer care and patient-centered approaches is driving the adoption of IGRT. However, high costs and the need for specialized equipment may restrain image guided radiotherapy market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Image Guided Radiotherapy. The growth and trends of Image Guided Radiotherapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Image Guided Radiotherapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Radiotherapy/LINAC (Linear Accelerators) Devices
Imaging Devices (CT Scan, MRI, PET Scan, Other Imaging Devices)

By Application

Breast Cancer
Lung Cancer
Brain Tumor
Prostate Cancer
Gastrointestinal Cancer
Gynecological Cancer
Other Applications

By End-Use

Hospitals
Radiotherapy Centers
Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Image Guided Radiotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Image Guided Radiotherapy market include Accuray Incorporated, C-RAD, Elekta, GE Healthcare, Hitachi Ltd., Philips, Siemens Healthineers, Varian Medical Systems Inc., ViewRay Inc., Vision RT Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112115403

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IMAGE GUIDED RADIOTHERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Radiotherapy/LINAC (Linear Accelerators) Devices Historic and Forecast Sales By Regions
5.4. Imaging Devices (CT Scan, MRI, PET Scan, Other Imaging Devices) Historic and Forecast Sales By Regions

6. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Breast Cancer Historic and Forecast Sales By Regions
6.4. Lung Cancer Historic and Forecast Sales By Regions
6.5. Brain Tumor Historic and Forecast Sales By Regions
6.6. Prostate Cancer Historic and Forecast Sales By Regions
6.7. Gastrointestinal Cancer Historic and Forecast Sales By Regions
6.8. Gynecological Cancer Historic and Forecast Sales By Regions
6.9. Other Applications Historic and Forecast Sales By Regions

7. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET ANALYSIS BY END-USE

7.1. Overview By End-Use
7.2. Historical and Forecast Data Analysis By End-Use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Radiotherapy Centers Historic and Forecast Sales By Regions
7.5. Other End-Users Historic and Forecast Sales By Regions

8. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE IMAGE GUIDED RADIOTHERAPY COMPANIES

9.1. Image Guided Radiotherapy Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF IMAGE GUIDED RADIOTHERAPY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Accuray Incorporated
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. C-RAD
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Elekta
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GE Healthcare
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Hitachi Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Philips
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Siemens Healthineers
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Varian Medical Systems Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. ViewRay Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Vision RT Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies